493 related articles for article (PubMed ID: 34742369)
41. Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030.
Sim SY; Watts E; Constenla D; Huang S; Brenzel L; Patenaude BN
Value Health; 2021 Jan; 24(1):70-77. PubMed ID: 33431156
[TBL] [Abstract][Full Text] [Related]
42. Can we use contingent valuation to assess the demand for childhood immunisation in developing countries?: a systematic review of the literature.
Yeung RY; Smith RD
Appl Health Econ Health Policy; 2005; 4(3):165-73. PubMed ID: 16309334
[TBL] [Abstract][Full Text] [Related]
43. Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches.
Watts E; Sim SY; Constenla D; Sriudomporn S; Brenzel L; Patenaude B
Value Health; 2021 Jan; 24(1):78-85. PubMed ID: 33431157
[TBL] [Abstract][Full Text] [Related]
44. Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-11, and requirements to meet 2015 targets.
Floyd K; Fitzpatrick C; Pantoja A; Raviglione M
Lancet Glob Health; 2013 Aug; 1(2):e105-e115. PubMed ID: 25104145
[TBL] [Abstract][Full Text] [Related]
45. Sources and Focus of Health Development Assistance, 1990-2014.
Dieleman JL; Graves C; Johnson E; Templin T; Birger M; Hamavid H; Freeman M; Leach-Kemon K; Singh L; Haakenstad A; Murray CJ
JAMA; 2015 Jun; 313(23):2359-68. PubMed ID: 26080340
[TBL] [Abstract][Full Text] [Related]
46. Progress on impoverishing health spending in 122 countries: a retrospective observational study.
Wagstaff A; Flores G; Smitz MF; Hsu J; Chepynoga K; Eozenou P
Lancet Glob Health; 2018 Feb; 6(2):e180-e192. PubMed ID: 29248366
[TBL] [Abstract][Full Text] [Related]
47. Tracking government spending on immunization: The joint reporting forms, national health accounts, comprehensive multi-year plans and co-financing data.
Ikilezi G; Bachmeier SD; Cogswell IE; Maddison ER; Stutzman HN; Tsakalos G; Brenzel L; Dieleman JL; Micah AE
Vaccine; 2021 Jun; 39(25):3410-3418. PubMed ID: 34020816
[TBL] [Abstract][Full Text] [Related]
48. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries.
Resch S; Ryckman T; Hecht R
Lancet Glob Health; 2015 Jan; 3(1):e52-61. PubMed ID: 25539970
[TBL] [Abstract][Full Text] [Related]
49. Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002-17.
Dingle A; Schäferhoff M; Borghi J; Lewis Sabin M; Arregoces L; Martinez-Alvarez M; Pitt C
Lancet Glob Health; 2020 Mar; 8(3):e374-e386. PubMed ID: 32035034
[TBL] [Abstract][Full Text] [Related]
50. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
[TBL] [Abstract][Full Text] [Related]
51. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
Abbas K; Procter SR; van Zandvoort K; Clark A; Funk S; Mengistu T; Hogan D; Dansereau E; Jit M; Flasche S;
Lancet Glob Health; 2020 Oct; 8(10):e1264-e1272. PubMed ID: 32687792
[TBL] [Abstract][Full Text] [Related]
52. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage.
Lim SS; Stein DB; Charrow A; Murray CJ
Lancet; 2008 Dec; 372(9655):2031-46. PubMed ID: 19070738
[TBL] [Abstract][Full Text] [Related]
53. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
54. The Impact of Conflict on Immunisation Coverage in 16 Countries.
Grundy J; Biggs BA
Int J Health Policy Manag; 2019 Apr; 8(4):211-221. PubMed ID: 31050966
[TBL] [Abstract][Full Text] [Related]
55. Countdown to 2015 country case studies: what can analysis of national health financing contribute to understanding MDG 4 and 5 progress?
Mann C; Ng C; Akseer N; Bhutta ZA; Borghi J; Colbourn T; Hernández-Peña P; Huicho L; Malik MA; Martinez-Alvarez M; Munthali S; Salehi AS; Tadesse M; Yassin M; Berman P;
BMC Public Health; 2016 Sep; 16 Suppl 2(Suppl 2):792. PubMed ID: 27634209
[TBL] [Abstract][Full Text] [Related]
56. Income Elasticity of Vaccines Spending versus General Healthcare Spending.
Alfonso YN; Ding G; Bishai D
Health Econ; 2016 Jul; 25(7):860-72. PubMed ID: 26010073
[TBL] [Abstract][Full Text] [Related]
57. Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
Leung GM; Tin KY; Yeung GM; Leung ES; Tsui EL; Lam DW; Tsang CS; Fung AY; Lo SV
Hong Kong Med J; 2008 Apr; 14 Suppl 2():2-23. PubMed ID: 18587162
[TBL] [Abstract][Full Text] [Related]
58. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1.
GBD 2020, Release 1, Vaccine Coverage Collaborators
Lancet; 2021 Aug; 398(10299):503-521. PubMed ID: 34273291
[TBL] [Abstract][Full Text] [Related]
59. Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?
Griffiths UK; Bozzani FM; Chansa C; Kinghorn A; Kalesha-Masumbu P; Rudd C; Chilengi R; Brenzel L; Schutte C
Vaccine; 2016 Jul; 34(35):4213-4220. PubMed ID: 27371102
[TBL] [Abstract][Full Text] [Related]
60. National vaccine coverage trends and funding in Latin America and the Caribbean.
Llau AF; Williams ML; Tejada CE
Vaccine; 2021 Jan; 39(2):317-323. PubMed ID: 33288342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
